Yüklüyor......
Clinical validity and utility of genetic risk scores in prostate cancer
Current issues related to prostate cancer (PCa) clinical care (e.g., over-screening, over-diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can be combined with family history (FH) to stratify disease risk among men in the general population. Since 2007, genome-...
Kaydedildi:
| Yayımlandı: | Asian J Androl |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955171/ https://ncbi.nlm.nih.gov/pubmed/27297129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.182981 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|